Yang, Fei <br/><br/>
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application.  [electronic resource] 

 -  The Journal of international medical research  May 2019 
 - 1817-1828 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1473-2300 
<br/><br/><label>Standard No.: </label>10.1177/0300060519837103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiomyopathies--diagnosis<br/>Cardiotonic Agents--therapeutic use<br/>Cardiotoxicity<br/>Humans<br/>Prognosis<br/>Sepsis--complications<br/>Simendan--therapeutic use